Is my portfolio
One Report to Answer all your Questions!
Natco Pharma Ltd.
BSE: 524816 | NSE: NATCOPHARM
Small Cap | Pharmaceuticals & Drugs
921.30
3.40 (0.37%) Natco Pharma informs about analyst meet
Date: 02-03-2024Natco Pharma has informed that it enclosed the disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Also informed that the officials of the Company will be participating in the investor meeting as on 06.03.2024.
The above information is a part of company’s filings submitted to BSE.